Post-transplant Colonization With Non-Aspergillus Molds and Risk of Development of Invasive Fungal Disease in Lung Transplant Recipients

Journal of Heart and Lung Transplantation

Volumn 27, Issue 8, 2008, Pages 850-855

  Silveira, Fernanda P ^a   Kwak, Eun J ^a   Paterson, David L ^a,b   Pilewski, Joseph M ^a   McCurry, Kenneth R ^a   Husain, Shahid ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; AMPHOTERICIN B; FLUCONAZOLE; VORICONAZOLE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; EMPHYSEMA; FEMALE; FOLLOW UP; FUNGAL COLONIZATION; FUNGUS ISOLATION; HEALTH HAZARD; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG LAVAGE; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MUCORMYCOSIS; PRIORITY JOURNAL; PROPHYLAXIS;

ADULT; AGED; ANTIFUNGAL AGENTS; BRONCHOALVEOLAR LAVAGE; CLADOSPORIUM; FEMALE; HUMANS; LUNG; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; MYCOSES; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 47649125233     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2008.05.021     Document Type: Article

References (23)

1. Singh N., and Husain S. Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management. J Heart Lung Transplant 22 (2003) 258-266
2. Husain S., Kwak E.J., Obman A., et al. Prospective assessment of Platelia Aspergillus galactomannan antigen for the diagnosis of invasive aspergillosis in lung transplant recipients. Am J Transplant 4 (2004) 796-802
3. Westney G.E., Kesten S., De Hoyos A., et al. Aspergillus infection in single and double lung transplant recipients. Transplantation 61 (1996) 915-919
4. Gordon S.M., and Avery R.K. Aspergillosis in lung transplantation: incidence, risk factors, and prophylactic strategies. Transplant Infect Dis 3 (2001) 161-167
5. Minari A., Husni R., Avery R.K., et al. The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants. Transplant Infect Dis 4 (2002) 195-200
6. Silveira F.P., and Husain S. Fungal infections in solid organ transplantation. Med Mycol 45 (2007) 305-320
7. Nucci M. Emerging moulds: Fusarium, Scedosporium and Zygomycetes in transplant recipients. Curr Opin Infect Dis 16 (2003) 607-612
8. Husain S., Paterson D.L., Studer S., et al. Voriconazole prophylaxis in lung transplant recipients. Am J Transplant 6 (2006) 3008-3016
9. Cahill B.C., Hibbs J.R., Savik K., et al. Aspergillus airway colonization and invasive disease after lung transplantation. Chest 112 (1997) 1160-1164
10. Aldape K.D., Fox H.S., Roberts J.P., et al. Cladosporium trichoides cerebral phaeohyphomycosis in a liver transplant recipient. Report of a case. Am J Clin Pathol 95 (1991) 499-502
11. Anandi V., John T.J., Walter A., et al. Cerebral phaeohyphomycosis caused by Chaetomium globosum in a renal transplant recipient. J Clin Microbiol 27 (1989) 2226-2229
12. Salama A.D., Rogers T., Lord G.M., Lechler R.I., and Mason P.D. Multiple Cladosporium brain abscesses in a renal transplant patient: aggressive management improves outcome. Transplantation 63 (1997) 160-162
13. Sahi H., Avery R.K., Minai O.A., et al. Scedosporium apiospermum (Pseudoallescheria boydii) infection in lung transplant recipients. J Heart Lung Transplant 26 (2007) 350-356
14. Symoens F., Knoop C., Schrooyen M., et al. Disseminated Scedosporium apiospermum infection in a cystic fibrosis patient after double-lung transplantation. J Heart Lung Transplant 25 (2006) 603-607
15. Mattner F., Weissbrodt H., and Strueber M. Two case reports: fatal Absidia corymbifera pulmonary tract infection in the first postoperative phase of a lung transplant patient receiving voriconazole prophylaxis, and transient bronchial Absidia corymbifera colonization in a lung transplant patient. Scand J Infect Dis 36 (2004) 312-314
16. McCurry K.R., Iacono A., Zeevi A., et al. Early outcomes in human lung transplantation with thymoglobulin or Campath-1H for recipient pretreatment followed by posttransplant tacrolimus near-monotherapy. J Thorac Cardiovasc Surg 130 (2005) 528-537
17. Ascioglu S., Rex J.H., de Pauw B., et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 34 (2002) 7-14
18. Husain S., Zaldonis D., Kusne S., et al. Variation in antifungal prophylaxis strategies in lung transplantation. Transplant Infect Dis 8 (2006) 213-218
19. Cornely O.A., Maertens J., Winston D.J., et al. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med 356 (2007) 348-359
20. Ullmann A.J., Lipton J.H., Vesole D.H., et al. Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med 356 (2007) 335-347
21. Clark T., Huhn G.D., Conover C., et al. Outbreak of bloodstream infection with the mold Phialemonium among patients receiving dialysis at a hemodialysis unit. Infect Control Hosp Epidemiol 27 (2006) 1164-1170
22. Scott R.S., Sutton D.A., and Jagirdar J. Lung infection due to opportunistic fungus, Phialemonium obovatum, in a bone marrow transplant recipient: an emerging infection with fungemia and Crohn disease-like involvement of the gastrointestinal tract. Ann Diagn Pathol 9 (2005) 227-230
23. Proia L.A., Hayden M.K., Kammeyer P.L., et al. Phialemonium: an emerging mold pathogen that caused 4 cases of hemodialysis-associated endovascular infection. Clin Infect Dis 39 (2004) 373-379